For more information, call: 877-CENTEGRA

A-Z Health Topics


Return to Index
by Badash M

Revisión para Enfermedad de Alzheimer

El propósito de la revisión es el diagnóstico y tratamiento tempranos. Los exámenes de revisión por lo general se administran a personas sin síntomas actuales, pero que podrían estar en alto riesgo de ciertas enfermedades o condiciones.

Exámenes o Indicaciones de Revisión

En este momento, no hay exámenes o indicaciones de revisión para la enfermedad de Alzheimer. Por lo general, la examinación no se inicia hasta que los síntomas se vuelven aparentes para el paciente o un miembro de la familia.

References

10 early signs and symptoms of Alzheimer's. Alzheimer’s Association website. Available at: http://www.alz.org/alzheimers%5Fdisease%5F10%5Fsigns%5Fof%5Falzheimers.asp. Accessed September 6, 2013.
Alzheimer dementia. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated August 19, 2013. Accessed September 6, 2013.
Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at: http://www.nia.nih.gov/Alzheimers/Publications/medicationsfs.htm. Updated July 22, 2013. Accessed September 6, 2013.
Drago V, Babiloni C, Bartres-Faz D, et al. Disease tracking markers for Alzheimer’s disease at the prodromal (MCI) stage. J Alzhemier’s Dis. 2011;26 Suppl 3:159-199.
Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560-574.
Roalf DR, Moberg PJ, Xie SX, et al. Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2012;9(5):529-537.
Wolk DA, Klunk W. Update on amyloid imaging: from healthy aging to Alzheimer's disease. Curr Neurol Neurosci Rep. 2009;9(5):345-352.
7/6/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Brown J, Pengas G, et al. Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ. 2009;338:b2030.

Revision Information